BridgeMD
New treatment option for Neuromuscular Blockade Monitoring
Official title NMT EasyFit Sensor and Cable
ClinicalTrials.gov ID: NCT07394140
What this study is testing
- What it's testing
- The purpose of this clinical study is to collect and assess feedback from clinical users regarding the functionality and device use and collection of raw parameter date from the NMT Sensor and NMT Cable.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Study subject (male or female) is age 18 years or older (≥18 years).
- Study subject must have the ability to understand and provide written informed consent.
- Study subject is undergoing a clinically indicated procedure requiring the use of paralytic medication.
- Study subject will have the primary NMT monitoring conducted using an NMT ElectroSensor on the hand/forearm.
You likely can't join if
- Are known to be pregnant.
- Are breastfeeding.
- Suffering from an infection(s) that requires isolation.
- Deformity, scar tissue, tattoos, or other characteristics at the sensor application area that could interfere (e.g., nerve damage) with the...
- people requiring rapid sequence induction
- people expected to be at risk from participation for any reason, such as those with known allergy or sensitivity to adhesive materials that may be...
See the full eligibility criteria
- Study subject (male or female) is age 18 years or older (≥18 years).
- Study subject must have the ability to understand and provide written informed consent.
- Study subject is undergoing a clinically indicated procedure requiring the use of paralytic medication.
- Study subject will have the primary NMT monitoring conducted using an NMT ElectroSensor on the hand/forearm.
- Are known to be pregnant.
- Are breastfeeding.
- Suffering from an infection(s) that requires isolation.
- Deformity, scar tissue, tattoos, or other characteristics at the sensor application area that could interfere (e.g., nerve damage) with the completion of the study procedure or identify a study subject.
- people requiring rapid sequence induction
- people expected to be at risk from participation for any reason, such as those with known allergy or sensitivity to adhesive materials that may be used in the study.
- Direct employees or contractors of GE HealthCare, or any company that makes NMT monitoring devices (sensors, cables, modules).
- NMT ElectroSensor placed on the foot/ankle
The study team makes the final eligibility decision.
Where it's taking place
- Loma Linda, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Loma Linda, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.